The class of chemical compounds known as SRrp130 inhibitors comprises a diverse group of molecules that interact with and modulate the splicing process, an essential mechanism in gene expression. These compounds are not uniform in structure but are instead defined by their ability to affect the spliceosome, the complex molecular machine responsible for removing introns from precursor messenger RNA (pre-mRNA). SRrp130, a component associated with the splicing machinery, plays a crucial role in the regulation and execution of splicing events. The compounds capable of inhibiting SRrp130 function by influencing the spliceosome can alter the splicing patterns of genes, which in turn can affect the maturation of mRNA. The direct inhibition of SRrp130 through these compounds is not achieved by a single mode of action but through a variety of mechanisms that target different aspects of the splicing cycle, from spliceosome assembly to the phosphorylation state of proteins involved in the splicing process.
The chemical compounds that are known to interact with the splicing machinery and thereby can inhibit SRrp130 function are characterized by their interaction with core components of the spliceosome, such as the SF3b complex, or through the modulation of phosphorylation processes crucial for spliceosome assembly and function. By binding to or inhibiting these targets, these compounds can disrupt the precise coordination required for splicing, leading to an indirect inhibition of SRrp130. Additionally, some of these compounds can cause the degradation of splicing factors or modulate the function of RNA-binding proteins, thereby exerting their influence on SRrp130. This class of inhibitors is not defined by a shared chemical structure but rather by the shared outcome of their interactions, which results in the modulation of splicing and the subsequent inhibition of SRrp130's role in this fundamental cellular process. The study of these compounds provides valuable insights into the modulation of splicing and the fine-tuning of gene expression, as well as into the broader implications of splicing regulation within cellular biology.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $290.00 $5572.00 $10815.00 $25000.00 $65000.00 $2781.00 | 63 | |
Pladienolide B targets the SF3b complex within the spliceosome. By disrupting normal spliceosome function, Pladienolide B could possibly inhibit SRrp130's involvement in pre-mRNA splicing. | ||||||
Chlorhexidine | 55-56-1 | sc-252568 | 1 g | $101.00 | 3 | |
Chlorhexidine inhibits the phosphorylation of SR proteins. Since SRrp130's function depends on the phosphorylation state of SR proteins, Chlorhexidine could possibly inhibit SRrp130 by altering these post-translational modifications. | ||||||
Tipifarnib | 192185-72-1 | sc-364637 | 10 mg | $720.00 | ||
Indisulam leads to the degradation of certain splicing factors, which in turn affects splicing patterns. This alteration could possibly inhibit SRrp130's function within the spliceosomal machinery. |